about
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.The spectrum of cognitive disorders in Parkinson's disease: a data-driven approach.Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Parkinson's disease subtypes show a specific link between dopaminergic and glucose metabolism in the striatum.Neural substrates of cognitive subtypes in Parkinson's disease: a 3-year longitudinal study.Quantifying short-term dynamics of Parkinson's disease using self-reported symptom data from an Internet social network.White matter hyperintensities in Parkinson's disease: do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes?A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors.Identifying the clusters within nonmotor manifestations in early Parkinson's disease by using unsupervised cluster analysis.Patterns of Motor and Non-Motor Features in Medication-Naïve ParkinsonismGBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.Move for change part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's diseaseMove for Change Part II: a European survey evaluating the impact of the EPDA Charter for people with Parkinson's diseaseNonmotor Features in Parkinson's Disease: What Are the Most Important Associated Factors?A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation AnalysisComplexity of dopamine metabolism.Parkinson's Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery CohortDelineating nonmotor symptoms in early Parkinson's disease and first-degree relativesResearch on the premotor symptoms of Parkinson's disease: clinical and etiological implications.Defining a comprehensive verotype using electronic health records for personalized medicine.Common variant rs356182 near SNCA defines a Parkinson's disease endophenotypeLewy pathology and neurodegeneration in premotor Parkinson's disease.Oxidative stress in genetic mouse models of Parkinson's disease.Different diagnostic criteria for Parkinson disease: what are the pitfalls?The pathomechanisms underlying Parkinson's disease.Early versus delayed initiation of pharmacotherapy in Parkinson's disease.Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.Nonmotor symptoms in sporadic versus familial forms of Parkinson's disease.Neuropathobiology of non-motor symptoms in Parkinson disease.Microstructural Changes within the Basal Ganglia Differ between Parkinson Disease Subtypes.Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson's Disease: Longitudinal Data from the Jönköping Parkinson Registry.Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.Patterns of cortical thinning in nondemented Parkinson's disease patients.Main determinants of physical activity levels in individuals with Parkinson's disease.Self-Perceived Pre-Motor Symptoms Load in Patients with Parkinson's Disease: A Retrospective Study.Resting-state functional connectivity as a marker of disease progression in Parkinson's disease: A longitudinal MEG study.
P2860
Q27686808-3B5F9F0D-CA15-428E-A9EB-00CC685570DBQ30593620-D76C16C0-93BF-4522-981F-BA0F8DD250B1Q31097087-5D46AC35-1544-4BB2-8ECC-8F0F94425A6DQ33644318-55D74243-4509-48AB-8DC1-24639F3489D6Q34374245-D5E2613E-A141-4EAF-9BFD-C6BEA7C1A1C4Q34560102-7FA996CA-A7F3-462D-BC16-69634D546FD6Q34576193-B1F6451F-5019-4293-BF59-CECB4B464239Q34611889-E81F9ED3-C332-4B40-B16E-D3BC93EC1C17Q34674177-8040C52F-A272-4C90-981C-894EE80BADE7Q35124218-C7BFC2EF-3A61-47B4-8E79-04ABB8D9BDB7Q35977440-3D93F8C6-C01B-4A50-8592-DCAB9D45FC0EQ36234536-7DDFD321-3355-42AE-8079-F0919321093DQ36371466-29AA4E2D-A9D3-4805-933E-4006BD0B2500Q36670937-FB8C496A-F7A5-4320-81C9-E570F6EE2AF4Q36861043-361894AB-FD12-494B-AF6F-B4C7AAD2C789Q36885946-6BAD18ED-5671-419E-97ED-396E83011F60Q36958208-631745E4-8D34-4E2D-AE4C-F308F0379D6BQ37044196-DB4B97DF-BA6A-4776-8B25-3BF4A6357729Q37279420-79D774F1-EFA8-4C82-B56F-CE88FDF6BDFCQ37374203-9CD7EBD0-53CA-4091-AF20-72FA7F677216Q37389466-D4DD26E0-2B38-4FFF-BAC3-473356650DDFQ37572904-FCB5C030-7BD9-4664-A873-A3A99665894CQ38003064-3167C59B-73BA-4A10-98DE-75C5E29BF652Q38029327-9A2E125A-0DE3-4BCF-9EBE-68B5DB530591Q38089628-90E3BBEC-BE66-4185-9EFF-5786510B87C6Q38182660-DC0C2551-CA26-43F4-B59D-B0D1FE8F4BEAQ38206403-F9F09F3B-8DDC-451F-A0E6-17CECDB98EDFQ38373533-34C6E099-922F-4200-843C-1908592129C4Q38430846-340F4C7B-B906-4B3F-8D0C-A28C327B963BQ38481481-A6F6095A-24B9-4301-AA63-211BEB7CA4BEQ38592102-2C3C151F-6EDD-4D91-A23B-D2BCDAB44AECQ38629441-1B93B4FC-08F4-46E2-A41E-5E6874C85A4FQ38761399-ADFBFD29-06DD-4B60-98B7-27EDCE6B4F7BQ38889950-F993438D-CD92-4BD8-B28D-006F8FB14CF9Q39151939-EB80D989-8CCC-4FFA-87F6-A79F19EB0D61Q39446817-A6935F66-A545-418D-8373-5E9660C9F426Q39839169-ECC52CB0-FB59-4E73-B874-C629AD6BE9D5Q39915362-921C89CE-242B-420A-BB99-6D295FBE0DACQ41037503-3EC88C6D-26D9-4B2F-8381-2973E2705052Q41846484-3181189B-0E1C-44B9-BB6A-A1EB988920A5
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Clinical subtypes of Parkinson's disease.
@en
Clinical subtypes of Parkinson's disease.
@nl
type
label
Clinical subtypes of Parkinson's disease.
@en
Clinical subtypes of Parkinson's disease.
@nl
prefLabel
Clinical subtypes of Parkinson's disease.
@en
Clinical subtypes of Parkinson's disease.
@nl
P2093
P2860
P356
P1433
P1476
Clinical subtypes of Parkinson's disease.
@en
P2093
Dagmar Verbaan
Fabrice Colas
Jacobus J van Hilten
Johan Marinus
Joost N Kok
Martine Visser
Pablo Martínez-Martín
Ray K Chaudhuri
Stephanie M van Rooden
P2860
P356
10.1002/MDS.23346
P407
P577
2010-11-16T00:00:00Z